Day One Biopharmaceuticals (DAWN) Short Interest Ratio & Short Volume → Kiss of death from Joe Biden (From Porter & Company) (Ad) Free DAWN Stock Alerts $13.27 -0.33 (-2.43%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Day One Biopharmaceuticals Short Interest DataCurrent Short Interest10,600,000 sharesPrevious Short Interest11,190,000 sharesChange Vs. Previous Month-5.27%Dollar Volume Sold Short$174.05 millionShort Interest Ratio9.7 Days to CoverLast Record DateMay 15, 2024Outstanding Shares87,390,000 sharesFloat Size60,580,000 sharesShort Percent of Float17.50%Today's Trading Volume1,107,972 sharesAverage Trading Volume864,432 sharesToday's Volume Vs. Average128% Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartDAWN Short Interest Over TimeDAWN Days to Cover Over TimeDAWN Percentage of Float Shorted Over Time Ad The Freeport SocietyNext President (Not Trump. Not Biden.)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________. Day One Biopharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202410,600,000 shares $174.05 million -5.3%17.5%9.7 $16.42 4/30/202411,190,000 shares $191.35 million +25.2%18.5%10.7 $17.10 4/15/20248,940,000 shares $123.82 million -0.5%15.2%10.6 $13.85 3/31/20248,980,000 shares $148.35 million -6.6%15.2%14.5 $16.52 3/15/20249,610,000 shares $138.29 million -0.9%16.3%16.6 $14.39 2/29/20249,700,000 shares $162.28 million -0.2%16.5%17.3 $16.73Next President (Not Trump. Not Biden.) (Ad)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________. 2/15/20249,720,000 shares $149.30 million +6.2%16.6%19.5 $15.36 1/31/20249,150,000 shares $137.71 million -15.3%15.5%17.4 $15.05 1/15/202410,800,000 shares $150.55 million +0.5%19.1%16.7 $13.94 12/31/202310,750,000 shares $156.95 million -2.3%19.0%15.1 $14.60 12/15/202311,000,000 shares $156.86 million +2.3%19.4%14.8 $14.26 11/30/202310,750,000 shares $124.49 million -0.7%19.0%13 $11.58 11/15/202310,830,000 shares $130.72 million -8.5%19.2%13.1 $12.07 10/31/202311,840,000 shares $140.07 million +4.3%21.0%14.1 $11.83 10/15/202311,350,000 shares $125.64 million -7.8%20.1%14.7 $11.07 9/30/202312,310,000 shares $151.04 million -0.5%21.3%16.7 $12.27 9/15/202312,370,000 shares $172.19 million +2.7%21.4%16 $13.92 8/31/202312,050,000 shares $162.55 million -0.2%20.4%13.2 $13.49 8/15/202312,070,000 shares $166.32 million -12.4%20.4%10.3 $13.78 7/31/202313,780,000 shares $182.45 million +1.0%30.1%11.5 $13.24 7/15/202313,640,000 shares $158.91 million -2.4%29.8%10.7 $11.65 6/30/202313,980,000 shares $166.92 million +3.5%30.6%11 $11.94 6/15/202313,510,000 shares $177.52 million +35.1%29.6%10.1 $13.14 5/31/202310,000,000 shares $133 million +7.2%21.5%8.8 $13.30 5/15/20239,330,000 shares $129.50 million +2.3%20.1%11.3 $13.88 4/30/20239,120,000 shares $113.09 million +16.0%20.0%11.7 $12.40 4/15/20237,860,000 shares $96.99 million +6.1%17.3%11.6 $12.34 3/31/20237,410,000 shares $99.07 million +11.3%16.3%10.7 $13.37 3/15/20236,660,000 shares $124.34 million +12.1%14.6%12.1 $18.67 2/28/20235,940,000 shares $109.41 million +4.4%13.0%10.7 $18.42 2/15/20235,690,000 shares $111.18 million +6.6%12.5%10.7 $19.54 1/31/20235,340,000 shares $116.25 million -4.5%11.6%10.1 $21.77 1/15/20235,590,000 shares $127.62 million +25.1%14.0%10.5 $22.83 12/30/20224,470,000 shares $96.19 million +3.5%11.2%8.4 $21.52 12/15/20224,320,000 shares $92.53 million -1.1%11.0%8.6 $21.42 11/30/20224,370,000 shares $92.78 million -4.2%11.1%7.3 $21.23 11/15/20224,560,000 shares $99.82 million -9.5%11.6%7.5 $21.89 10/31/20225,040,000 shares $106.55 million -7.9%12.7%7.7 $21.14 10/15/20225,470,000 shares $114.21 million -8.5%14.6%8.5 $20.88 9/30/20225,980,000 shares $119.78 million -3.1%17.0%9.5 $20.03Truth about Trump you’ve never heard (Ad)Everything about Donald Trump is public. Every part of his life has been dragged out in the media. But there’s one story I bet you’ve never heard about Trump. For the full story, click here. 9/15/20226,170,000 shares $140.55 million -9.3%17.5%9 $22.78 8/31/20226,800,000 shares $159.73 million -6.7%21.3%4 $23.49 8/15/20227,290,000 shares $182.25 million -0.7%22.9%4.2 $25.00 7/31/20227,340,000 shares $125.73 million -6.0%24.3%4.4 $17.13 7/15/20227,810,000 shares $149.48 million +8.2%25.8%4.8 $19.14 6/30/20227,220,000 shares $129.24 million +0.6%23.2%4.5 $17.90 6/15/20227,180,000 shares $109.50 million +37.3%28.1%4.8 $15.25 5/31/20225,230,000 shares $32.53 million +9.2%23.8%17.8 $6.22 5/15/20224,790,000 shares $36.64 million +11.1%21.8%21.1 $7.65 4/30/20224,310,000 shares $36.72 million +6.4%19.8%20.2 $8.52 4/15/20224,050,000 shares $45.85 million +2.3%18.6%18.6 $11.32 3/31/20223,960,000 shares $39.28 million +0.5%N/A16.7 $9.92 3/15/20223,940,000 shares $41.29 million -1.3%18.1%16.1 $10.48 2/28/20223,990,000 shares $54.50 million +0.8%18.4%15.1 $13.66 2/15/20223,960,000 shares $54.61 million +4.8%18.2%14.6 $13.79 1/31/20223,780,000 shares $55.76 million +11.2%17.2%15.3 $14.75 1/15/20223,400,000 shares $47.91 million -1.2%N/A15.3 $14.09 12/31/20213,440,000 shares $57.96 million +30.3%14.8%18.7 $16.85 12/15/20212,640,000 shares $48.18 million +38.2%11.4%16 $18.25 11/30/20211,910,000 shares $35.09 million +6.1%8.8%16.2 $18.37 11/15/20211,800,000 shares $38.27 million -3.7%8.6%19.1 $21.26 10/29/20211,870,000 shares $45.70 million +1.6%8.9%17.7 $24.44 10/15/20211,840,000 shares $40.76 million +3.4%8.8%17.1 $22.15 9/30/20211,780,000 shares $42.24 million +6.6%8.5%16.2 $23.73 9/15/20211,670,000 shares $41.63 million +7.7%8.0%14.9 $24.93 8/31/20211,550,000 shares $43.14 million +22.1%7.8%19 $27.83 8/13/20211,270,000 shares $31.17 million No Change6.4%8.8 $24.54 DAWN Short Interest - Frequently Asked Questions What is Day One Biopharmaceuticals' current short interest? Short interest is the volume of Day One Biopharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 10,600,000 shares of DAWN short. 17.50% of Day One Biopharmaceuticals' shares are currently sold short. Learn More on Day One Biopharmaceuticals' current short interest. What is a good short interest ratio for Day One Biopharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DAWN shares currently have a short interest ratio of 10.0. Learn More on Day One Biopharmaceuticals's short interest ratio. Which institutional investors are shorting Day One Biopharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Day One Biopharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Day One Biopharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 17.50% of Day One Biopharmaceuticals' floating shares are currently sold short. Is Day One Biopharmaceuticals' short interest increasing or decreasing? Day One Biopharmaceuticals saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 10,600,000 shares, a drop of 5.3% from the previous total of 11,190,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Day One Biopharmaceuticals' float size? Day One Biopharmaceuticals currently has issued a total of 87,390,000 shares. Some of Day One Biopharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Day One Biopharmaceuticals currently has a public float of 60,580,000 shares. How does Day One Biopharmaceuticals' short interest compare to its competitors? 17.50% of Day One Biopharmaceuticals' shares are currently sold short. Here is how the short interest of companies compare to Day One Biopharmaceuticals: AbCellera Biologics Inc. (9.58%), Mirum Pharmaceuticals, Inc. (18.69%), Calliditas Therapeutics AB (publ) (0.03%), Collegium Pharmaceutical, Inc. (21.67%), MannKind Co. (13.13%), Enliven Therapeutics, Inc. (19.75%), Prothena Co. plc (12.11%), ANI Pharmaceuticals, Inc. (0.97%), Spyre Therapeutics, Inc. (12.85%), Cassava Sciences, Inc. (26.68%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Day One Biopharmaceuticals stock? Short selling DAWN is an investing strategy that aims to generate trading profit from Day One Biopharmaceuticals as its price is falling. DAWN shares are trading down $0.30 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Day One Biopharmaceuticals? A short squeeze for Day One Biopharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DAWN, which in turn drives the price of the stock up even further. How often is Day One Biopharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DAWN, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ABCL Short Interest MIRM Short Interest CALT Short Interest COLL Short Interest MNKD Short Interest ELVN Short Interest PRTA Short Interest ANIP Short Interest SYRE Short Interest SAVA Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DAWN) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWho are Nvidia’s New Silent Partners?Weiss RatingsMissed NVDA? Buy this AI stock NOWChaikin Analytics41 banks launch ‘crypto dollar’Stansberry ResearchGold Set to EXPLODE!Gold Safe ExchangeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin Pro Adding Choose a watchlist: Watchlist My Default Watchlist Adding Day One Biopharmaceuticals, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.